143 related articles for article (PubMed ID: 30925760)
21. Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis.
Ferreira M; Teixeira A; Maurício J; Lobo F; Morais A; Medeiros R
Urol Oncol; 2017 Aug; 35(8):532.e25-532.e30. PubMed ID: 28476527
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-10 (IL-10) promoter genotypes are associated with lung cancer risk in Taiwan males and smokers.
Hsia TC; Chang WS; Liang SJ; Chen WC; Tu CY; Chen HJ; Yang MD; Tsai CW; Hsu CM; Tsai CH; Bau DT
Anticancer Res; 2014 Dec; 34(12):7039-44. PubMed ID: 25503130
[TBL] [Abstract][Full Text] [Related]
23. Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study.
Shen BL; Qu QS; Miao SZ; Zhang YX
Genet Mol Res; 2015 Sep; 14(3):11119-25. PubMed ID: 26400342
[TBL] [Abstract][Full Text] [Related]
24. Association of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinoma.
Ajaz S; Khaliq S; Abid A; Hassan AS; Hashmi A; Sultan G; Mohsin R; Mubarrak M; Naqvi SA; Rizvi SA; Mehdi SQ
Genet Test Mol Biomarkers; 2011 Sep; 15(9):653-7. PubMed ID: 21491998
[TBL] [Abstract][Full Text] [Related]
25. Significant Contribution of DNA Repair
Chang WS; Shen TC; Liao JM; Tsai YT; Hsia TC; Wu HC; Tsai CW; Bau DT
Onco Targets Ther; 2020; 13():1583-1591. PubMed ID: 32110055
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-16 rs4778889 polymorphism contributes to the development of renal cell cancer in a Chinese population.
Wang Z; Xu Y; Zhu S
Int J Clin Exp Pathol; 2015; 8(11):15228-33. PubMed ID: 26823871
[TBL] [Abstract][Full Text] [Related]
27. Significant Contribution of Interleukin-18 Genotypes to Lung Cancer Risk in Taiwanese.
Wu MF; Chen LH; Hsia NY; Shen YC; Shen TC; Wang ZH; Yang YC; Wang YC; Chang WS; Hsia TC; Bau DT; Tsai CW
Anticancer Res; 2022 Jul; 42(7):3381-3387. PubMed ID: 35790262
[TBL] [Abstract][Full Text] [Related]
28. The role of XRCC6 T-991C functional polymorphism in renal cell carcinoma.
Chang WS; Ke HL; Tsai CW; Lien CS; Liao WL; Lin HH; Lee MH; Wu HC; Chang CH; Chen CC; Lee HZ; Bau DT
Anticancer Res; 2012 Sep; 32(9):3855-60. PubMed ID: 22993329
[TBL] [Abstract][Full Text] [Related]
29. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
[TBL] [Abstract][Full Text] [Related]
30. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
31. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
32. A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma.
Romero JM; Sáenz-López P; Cózar JM; Carretero R; Canton J; Vazquez F; Concha A; Tallada M; Garrido F; Ruiz-Cabello F
Hum Immunol; 2009 Jan; 70(1):60-4. PubMed ID: 19027043
[TBL] [Abstract][Full Text] [Related]
33. Impact of glutathione transferase M1, T1, and P1 gene polymorphisms in the genetic susceptibility of North Indian population to renal cell carcinoma.
Ahmad ST; Arjumand W; Seth A; Kumar Saini A; Sultana S
DNA Cell Biol; 2012 Apr; 31(4):636-43. PubMed ID: 22054067
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-4-receptor alpha gene polymorphism and the risk of renal cell carcinoma in a South Indian population.
Mohan S; Mohanasenthil ; Paul SF; Shroff S; Venkatesan V
Asian Pac J Cancer Prev; 2009; 10(2):295-8. PubMed ID: 19548368
[TBL] [Abstract][Full Text] [Related]
35. The vitamin D receptor gene ApaI polymorphism is associated with increased risk of renal cell carcinoma in Chinese population.
Yang C; Li J; Li Y; Wu D; Sui C; Jiang Y; Meng F
Sci Rep; 2016 May; 6():25987. PubMed ID: 27174575
[TBL] [Abstract][Full Text] [Related]
36. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
37. Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma.
Baştürk B; Yavaşçaoğlu I; Vuruşkan H; Göral G; Oktay B; Oral HB
Cytokine; 2005 Apr; 30(1):41-5. PubMed ID: 15784411
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
[TBL] [Abstract][Full Text] [Related]
39. [Association between interleukin-18 gene polymorphisms and hepatocellular carcinoma caused by hepatitis B virus].
Zhang QX; Yao YQ; Li SL; Long Q
Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):352-7. PubMed ID: 27470888
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas.
Xian W; Zheng H; Wu WJ
Genet Mol Res; 2015 Jul; 14(3):7634-42. PubMed ID: 26214443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]